Christian Johannes Gloeckner

Title: Christian Johannes Gloeckner: Innovator in Neurodegenerative Disorder Research

Introduction

Christian Johannes Gloeckner is a notable inventor based in Rottenburg-Hailfingen, Germany. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and discoveries. With a total of two patents to his name, Gloeckner's work focuses on the detection and treatment of conditions such as Parkinson's disease and Alzheimer's disease.

Latest Patents

Gloeckner's latest patents include the KASPP (LRRK2) gene, which is crucial for the detection and treatment of neurodegenerative disorders. This invention refers to a newly discovered gene named KASPP, or Kinase Associated with Parkinsonism with Pleiomorphic Pathology, alternatively known as LRRK2, or Leucine-Rich Repeat Kinase 2. The patent details the gene's production, biochemical characterization, and its application in diagnosing and treating various neurodegenerative disorders, including sporadic Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and other related conditions.

Career Highlights

Throughout his career, Gloeckner has worked with esteemed institutions such as Eberhard Karls Universität Tübingen and the Mayo Foundation for Medical Education and Research. His research has significantly advanced the understanding of neurodegenerative diseases and their underlying genetic factors.

Collaborations

Gloeckner has collaborated with notable colleagues, including Thomas Meitinger and Tim Matthias Strom, contributing to a rich exchange of ideas and research findings in the field of genetics and neurodegenerative disorders.

Conclusion

Christian Johannes Gloeckner's innovative work in the field of neurodegenerative disorders highlights the importance of genetic research in developing effective treatments. His contributions continue to pave the way for advancements in understanding and addressing these complex diseases.